Idaho Did Not Bill Manufacturers for Rebates for Some Medicaid Physician-Administered Drugs

摘要

For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid programs drug rebate requirements, manufacturers must pay rebates to the States. States bill the manufacturers for the rebates to reduce the cost of the drugs to the program. However, a recent Office of Inspector General review found that States did not always bill and collect all rebates due for drugs administered by physicians. The objective was to determine whether Idahos Department of Health and Welfare (State agency) complied with Federal Medicaid requirements for billing manufacturers for rebates for physician-administered drugs.